Current biologic use but not previous biologic use decreases the risk of cardiovascular events in patients with inflammatory arthritis, Australian figures show. The findings come from a study of data from more than 4,000 patients on the Australian Rheumatology Association Database (ARAD) with a diagnosis of rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Follow-up was for ...
Cardiovascular benefit from RA biologics
By Mardi Chapman
14 Aug 2018